

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.29871992 |
| 2 | cytidine metabolic process (GO:0046087) | 5.24236366 |
| 3 | cytidine catabolic process (GO:0006216) | 5.24236366 |
| 4 | cytidine deamination (GO:0009972) | 5.24236366 |
| 5 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.15147113 |
| 6 | DNA deamination (GO:0045006) | 4.82868188 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.66832151 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66832151 |
| 9 | regulation of memory T cell differentiation (GO:0043380) | 4.56910648 |
| 10 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.47548786 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.47165286 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.42136543 |
| 13 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.40532390 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24535796 |
| 15 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 4.22466580 |
| 16 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.20240525 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.11757554 |
| 18 | positive thymic T cell selection (GO:0045059) | 4.06824438 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.03778545 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00825299 |
| 21 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.00623927 |
| 22 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.99368254 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 3.93156405 |
| 24 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.79392648 |
| 25 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.77860551 |
| 26 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.77860551 |
| 27 | * positive regulation of cell killing (GO:0031343) | 3.75528325 |
| 28 | parturition (GO:0007567) | 3.69447331 |
| 29 | mast cell activation (GO:0045576) | 3.68824219 |
| 30 | regulation of T cell chemotaxis (GO:0010819) | 3.64395707 |
| 31 | positive regulation of T cell chemotaxis (GO:0010820) | 3.64395707 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63433748 |
| 33 | * regulation of cell killing (GO:0031341) | 3.61873630 |
| 34 | regulation of chronic inflammatory response (GO:0002676) | 3.58533508 |
| 35 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.55394655 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53749233 |
| 37 | positive regulation of defense response to virus by host (GO:0002230) | 3.49030867 |
| 38 | * regulation of regulatory T cell differentiation (GO:0045589) | 3.47531546 |
| 39 | interferon-gamma production (GO:0032609) | 3.44837573 |
| 40 | positive T cell selection (GO:0043368) | 3.44668377 |
| 41 | thymic T cell selection (GO:0045061) | 3.35212211 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34854325 |
| 43 | positive regulation of lymphocyte migration (GO:2000403) | 3.34391875 |
| 44 | negative T cell selection (GO:0043383) | 3.31185373 |
| 45 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.26375755 |
| 46 | positive regulation of T cell migration (GO:2000406) | 3.25377077 |
| 47 | response to interleukin-15 (GO:0070672) | 3.25225605 |
| 48 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.23560879 |
| 49 | interferon-gamma secretion (GO:0072643) | 3.15152738 |
| 50 | negative regulation of T cell apoptotic process (GO:0070233) | 3.10397382 |
| 51 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.08728650 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07059083 |
| 53 | response to interferon-beta (GO:0035456) | 3.04625820 |
| 54 | regulation of T cell migration (GO:2000404) | 3.04337039 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.03958793 |
| 56 | response to protozoan (GO:0001562) | 3.01738516 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00094819 |
| 58 | T-helper cell differentiation (GO:0042093) | 2.99917828 |
| 59 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.99917828 |
| 60 | neutrophil activation (GO:0042119) | 2.97828690 |
| 61 | positive regulation of interferon-gamma production (GO:0032729) | 2.97451505 |
| 62 | neutrophil activation involved in immune response (GO:0002283) | 2.96220977 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.92335888 |
| 64 | mitochondrial calcium ion transport (GO:0006851) | 2.92112648 |
| 65 | negative regulation of viral genome replication (GO:0045071) | 2.91178796 |
| 66 | regulation of lymphocyte migration (GO:2000401) | 2.90859918 |
| 67 | * positive regulation of T cell mediated immunity (GO:0002711) | 2.89399481 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.89300183 |
| 69 | T cell selection (GO:0045058) | 2.87551773 |
| 70 | T cell differentiation involved in immune response (GO:0002292) | 2.87016343 |
| 71 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.87016343 |
| 72 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.87016343 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87014837 |
| 74 | granulocyte activation (GO:0036230) | 2.86115563 |
| 75 | actin nucleation (GO:0045010) | 2.84339493 |
| 76 | defense response to protozoan (GO:0042832) | 2.83738645 |
| 77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.82598583 |
| 78 | lymph node development (GO:0048535) | 2.79195496 |
| 79 | * type I interferon signaling pathway (GO:0060337) | 2.77475153 |
| 80 | * cellular response to type I interferon (GO:0071357) | 2.77475153 |
| 81 | * response to type I interferon (GO:0034340) | 2.76489604 |
| 82 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.75402064 |
| 83 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.74923415 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 2.74526855 |
| 85 | negative regulation of T cell differentiation (GO:0045581) | 2.73288604 |
| 86 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.73142416 |
| 87 | T cell receptor signaling pathway (GO:0050852) | 2.72325953 |
| 88 | negative regulation of type 2 immune response (GO:0002829) | 2.69578297 |
| 89 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.69567317 |
| 90 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.67131303 |
| 91 | positive regulation of interleukin-17 production (GO:0032740) | 2.64099678 |
| 92 | negative regulation of viral entry into host cell (GO:0046597) | 2.63956597 |
| 93 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.63461856 |
| 94 | immunoglobulin mediated immune response (GO:0016064) | 2.61826508 |
| 95 | T cell migration (GO:0072678) | 2.61626823 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.61430517 |
| 97 | * regulation of T cell mediated immunity (GO:0002709) | 2.61323398 |
| 98 | * cellular defense response (GO:0006968) | 2.61196462 |
| 99 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60879990 |
| 100 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.59706963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.77402957 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.82434578 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.79944322 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.58034332 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.09032517 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.92312732 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.80133650 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49335921 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47879475 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39759351 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.29616125 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18848714 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09922083 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03958159 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99828226 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99731568 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 1.93036366 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86536689 |
| 19 | GATA3_26560356_Chip-Seq_TH2_Human | 1.80740981 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80475159 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68567562 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63212241 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61152289 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56410661 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.51281814 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51117156 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46873247 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.46493976 |
| 29 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.43586597 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40881227 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34277755 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32421256 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31389122 |
| 34 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30046466 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28877526 |
| 36 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.28403459 |
| 37 | P300_27268052_Chip-Seq_Bcells_Human | 1.27079274 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26217910 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25686212 |
| 40 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.24462214 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23281740 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21265718 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20704754 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20610585 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17741098 |
| 46 | SA1_27219007_Chip-Seq_Bcells_Human | 1.16946420 |
| 47 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16704918 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14507021 |
| 49 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14012800 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13017016 |
| 51 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12985573 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12966822 |
| 53 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.08467201 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07764180 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07718868 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03936281 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02782877 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02334685 |
| 59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01684904 |
| 60 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01615316 |
| 61 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01326051 |
| 62 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99708330 |
| 63 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99590436 |
| 64 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99214904 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98814640 |
| 66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97677831 |
| 67 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96835647 |
| 68 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96217734 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95911135 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94358459 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93845945 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93660370 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92597726 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92451619 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91666870 |
| 76 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90701488 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89180592 |
| 78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89137668 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88238073 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88056809 |
| 81 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87341016 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87333885 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86852541 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85577030 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85304322 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85289981 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85164683 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84431128 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84310944 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83704816 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83022034 |
| 92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82783911 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82536104 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.82090174 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82077359 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.80111595 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 0.78957631 |
| 98 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.78794372 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78484337 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78130493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.35840930 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.42722048 |
| 3 | MP0009785_altered_susceptibility_to | 3.33878281 |
| 4 | MP0003436_decreased_susceptibility_to | 2.88397739 |
| 5 | MP0003724_increased_susceptibility_to | 2.84606318 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.68192919 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.64515117 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 2.60162139 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 2.54706619 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.44639512 |
| 11 | MP0001800_abnormal_humoral_immune | 2.44436333 |
| 12 | MP0004381_abnormal_hair_follicle | 2.43525441 |
| 13 | MP0001790_abnormal_immune_system | 2.41619025 |
| 14 | MP0005387_immune_system_phenotype | 2.41619025 |
| 15 | MP0000685_abnormal_immune_system | 2.32778054 |
| 16 | MP0005025_abnormal_response_to | 2.31767552 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.30423941 |
| 18 | MP0002723_abnormal_immune_serum | 2.27777810 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.16421220 |
| 20 | MP0003866_abnormal_defecation | 2.15306755 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.14928364 |
| 22 | MP0001873_stomach_inflammation | 2.11518416 |
| 23 | MP0003646_muscle_fatigue | 2.09636699 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.07156461 |
| 25 | MP0001819_abnormal_immune_cell | 2.03286352 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.01805178 |
| 27 | MP0005171_absent_coat_pigmentation | 1.97158171 |
| 28 | MP0001919_abnormal_reproductive_system | 1.87061019 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.85501958 |
| 30 | MP0002419_abnormal_innate_immunity | 1.85210854 |
| 31 | MP0004947_skin_inflammation | 1.83951120 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.83065988 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.77839117 |
| 34 | MP0003136_yellow_coat_color | 1.72512147 |
| 35 | MP0003878_abnormal_ear_physiology | 1.67326696 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.67326696 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.62379657 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.59326818 |
| 39 | MP0006082_CNS_inflammation | 1.58425849 |
| 40 | MP0002405_respiratory_system_inflammati | 1.57658936 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.52477990 |
| 42 | MP0009764_decreased_sensitivity_to | 1.48833806 |
| 43 | MP0000716_abnormal_immune_system | 1.45531202 |
| 44 | MP0002006_tumorigenesis | 1.42297091 |
| 45 | MP0002398_abnormal_bone_marrow | 1.38434939 |
| 46 | MP0002933_joint_inflammation | 1.32149336 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.30679120 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.27384254 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.26306990 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.20544745 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.19955415 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.18799676 |
| 53 | MP0002722_abnormal_immune_system | 1.18575691 |
| 54 | MP0001851_eye_inflammation | 1.17055388 |
| 55 | MP0000371_diluted_coat_color | 1.15591049 |
| 56 | MP0008469_abnormal_protein_level | 1.13405710 |
| 57 | MP0000604_amyloidosis | 1.13127779 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.12411638 |
| 59 | MP0003045_fibrosis | 1.12017439 |
| 60 | MP0002429_abnormal_blood_cell | 1.08659589 |
| 61 | MP0003638_abnormal_response/metabolism_ | 1.07535116 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.04587243 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.03677119 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.01000196 |
| 65 | MP0002254_reproductive_system_inflammat | 0.99163427 |
| 66 | MP0003786_premature_aging | 0.98670011 |
| 67 | MP0005408_hypopigmentation | 0.98647584 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 0.95379523 |
| 69 | MP0001765_abnormal_ion_homeostasis | 0.94343691 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.93522027 |
| 71 | MP0000703_abnormal_thymus_morphology | 0.92506120 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.91845367 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 0.89650551 |
| 74 | MP0005166_decreased_susceptibility_to | 0.88173295 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.87474198 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.86890076 |
| 77 | MP0003075_altered_response_to | 0.86008855 |
| 78 | MP0008872_abnormal_physiological_respon | 0.85613384 |
| 79 | MP0005389_reproductive_system_phenotype | 0.84437935 |
| 80 | MP0005310_abnormal_salivary_gland | 0.80653768 |
| 81 | MP0009763_increased_sensitivity_to | 0.80303242 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.80158712 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79591237 |
| 84 | MP0003303_peritoneal_inflammation | 0.78860766 |
| 85 | MP0005410_abnormal_fertilization | 0.78267969 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.77295953 |
| 87 | MP0002075_abnormal_coat/hair_pigmentati | 0.76376815 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.75562087 |
| 89 | MP0001905_abnormal_dopamine_level | 0.75428607 |
| 90 | MP0003448_altered_tumor_morphology | 0.75090610 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.74618847 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.73891740 |
| 93 | MP0002102_abnormal_ear_morphology | 0.71023634 |
| 94 | MP0004742_abnormal_vestibular_system | 0.69239101 |
| 95 | MP0005390_skeleton_phenotype | 0.68596369 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.68267531 |
| 97 | MP0005253_abnormal_eye_physiology | 0.68213425 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.68174319 |
| 99 | MP0004147_increased_porphyrin_level | 0.68118211 |
| 100 | MP0001663_abnormal_digestive_system | 0.68032315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.83947423 |
| 2 | Abnormality of T cell number (HP:0011839) | 4.61520319 |
| 3 | IgG deficiency (HP:0004315) | 4.41303079 |
| 4 | Abnormality of B cell number (HP:0010975) | 3.88106310 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72187706 |
| 6 | Abnormality of T cells (HP:0002843) | 3.65444946 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 3.48449236 |
| 8 | B lymphocytopenia (HP:0010976) | 3.45144239 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.38268356 |
| 10 | Optic neuritis (HP:0100653) | 3.38268356 |
| 11 | Axonal loss (HP:0003447) | 3.36178492 |
| 12 | Myositis (HP:0100614) | 3.22328397 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.16363698 |
| 14 | Pustule (HP:0200039) | 3.14552661 |
| 15 | Stomatitis (HP:0010280) | 3.09286191 |
| 16 | Pulmonary infiltrates (HP:0002113) | 3.08846004 |
| 17 | Chronic diarrhea (HP:0002028) | 3.07458548 |
| 18 | Orchitis (HP:0100796) | 3.02656271 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99920142 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99920142 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99920142 |
| 22 | Meningitis (HP:0001287) | 2.83519124 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 2.82530309 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 2.82394044 |
| 25 | Increased IgM level (HP:0003496) | 2.82360769 |
| 26 | Hypoproteinemia (HP:0003075) | 2.81357396 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.78781920 |
| 28 | Combined immunodeficiency (HP:0005387) | 2.74495070 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73933656 |
| 30 | Abnormality of the prostate (HP:0008775) | 2.72477995 |
| 31 | Gangrene (HP:0100758) | 2.70524916 |
| 32 | Abnormality of eosinophils (HP:0001879) | 2.68110498 |
| 33 | Recurrent bronchitis (HP:0002837) | 2.65563117 |
| 34 | Hypoplasia of the fovea (HP:0007750) | 2.63386743 |
| 35 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.63386743 |
| 36 | Conical tooth (HP:0000698) | 2.58787267 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.58087230 |
| 38 | Vasculitis (HP:0002633) | 2.56168366 |
| 39 | Thyroiditis (HP:0100646) | 2.51110877 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50813514 |
| 41 | Tetany (HP:0001281) | 2.50794290 |
| 42 | Joint swelling (HP:0001386) | 2.49431851 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.49358130 |
| 44 | Encephalitis (HP:0002383) | 2.44496061 |
| 45 | Eosinophilia (HP:0001880) | 2.43131685 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41631275 |
| 47 | Stomach cancer (HP:0012126) | 2.38585244 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.37979348 |
| 49 | Hemoptysis (HP:0002105) | 2.37450237 |
| 50 | Spastic paraparesis (HP:0002313) | 2.36049260 |
| 51 | Abnormality of macular pigmentation (HP:0008002) | 2.35376731 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.32577365 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.32142895 |
| 54 | Adactyly (HP:0009776) | 2.31449045 |
| 55 | Hypomagnesemia (HP:0002917) | 2.28038551 |
| 56 | IgM deficiency (HP:0002850) | 2.27481291 |
| 57 | Renal cortical cysts (HP:0000803) | 2.26684765 |
| 58 | Fibular aplasia (HP:0002990) | 2.25077661 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.24868534 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.24836811 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.24009555 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.23763346 |
| 63 | Congenital, generalized hypertrichosis (HP:0004540) | 2.21638079 |
| 64 | Prostate neoplasm (HP:0100787) | 2.21458974 |
| 65 | Leukocytosis (HP:0001974) | 2.19279488 |
| 66 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.17456374 |
| 67 | Granulocytopenia (HP:0001913) | 2.13624884 |
| 68 | Abnormality of the fovea (HP:0000493) | 2.13057393 |
| 69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.11582735 |
| 70 | Recurrent skin infections (HP:0001581) | 2.07240123 |
| 71 | Sparse eyelashes (HP:0000653) | 2.04686732 |
| 72 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.04581306 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.02715493 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.02715493 |
| 75 | Recurrent viral infections (HP:0004429) | 2.00342039 |
| 76 | Abnormality of the renal cortex (HP:0011035) | 1.99376852 |
| 77 | Abolished electroretinogram (ERG) (HP:0000550) | 1.99241558 |
| 78 | Eczematoid dermatitis (HP:0000976) | 1.98202833 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97647899 |
| 80 | Abnormal drinking behavior (HP:0030082) | 1.95503815 |
| 81 | Polydipsia (HP:0001959) | 1.95503815 |
| 82 | Albinism (HP:0001022) | 1.94868513 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94352913 |
| 84 | Obstructive lung disease (HP:0006536) | 1.94352913 |
| 85 | Inflammation of the large intestine (HP:0002037) | 1.93802624 |
| 86 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92480133 |
| 87 | Alkalosis (HP:0001948) | 1.91022202 |
| 88 | Anorexia (HP:0002039) | 1.89760963 |
| 89 | Pulmonary fibrosis (HP:0002206) | 1.89104600 |
| 90 | Abnormality of the alveolar ridges (HP:0006477) | 1.88697702 |
| 91 | Abnormality of the pleura (HP:0002103) | 1.85639299 |
| 92 | Arterial thrombosis (HP:0004420) | 1.85184264 |
| 93 | Visual hallucinations (HP:0002367) | 1.84526388 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 1.82767249 |
| 95 | Attenuation of retinal blood vessels (HP:0007843) | 1.81818498 |
| 96 | Lymphopenia (HP:0001888) | 1.81395964 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 1.81227902 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80642294 |
| 99 | Increased serum ferritin (HP:0003281) | 1.80379728 |
| 100 | Polyneuropathy (HP:0001271) | 1.80183670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.20987521 |
| 2 | MAP4K1 | 4.14690202 |
| 3 | WNK4 | 3.98420950 |
| 4 | TAOK3 | 3.21010960 |
| 5 | TLK1 | 3.20850031 |
| 6 | STK39 | 3.06476822 |
| 7 | KDR | 2.56056469 |
| 8 | IKBKE | 2.13251856 |
| 9 | GRK6 | 2.10527234 |
| 10 | BCKDK | 2.05571414 |
| 11 | MAPKAPK3 | 2.04162659 |
| 12 | TESK2 | 1.94643461 |
| 13 | MAP3K14 | 1.92836131 |
| 14 | MAP2K2 | 1.88629887 |
| 15 | TIE1 | 1.85307611 |
| 16 | ADRBK2 | 1.78877299 |
| 17 | ZAP70 | 1.78814801 |
| 18 | IKBKB | 1.73122335 |
| 19 | FES | 1.72384808 |
| 20 | ITK | 1.68653585 |
| 21 | SCYL2 | 1.66955735 |
| 22 | SYK | 1.63555205 |
| 23 | MAP2K6 | 1.60652954 |
| 24 | TBK1 | 1.58865830 |
| 25 | ZAK | 1.43879163 |
| 26 | JAK3 | 1.36633174 |
| 27 | PRKCQ | 1.32591945 |
| 28 | PINK1 | 1.31573303 |
| 29 | TEC | 1.30817831 |
| 30 | BTK | 1.26570098 |
| 31 | MAP4K2 | 1.23982712 |
| 32 | MAPK11 | 1.18370128 |
| 33 | CSK | 1.17028118 |
| 34 | GRK1 | 1.13735780 |
| 35 | LCK | 1.11813400 |
| 36 | RIPK4 | 1.10980555 |
| 37 | MARK3 | 1.10564828 |
| 38 | KIT | 1.10046470 |
| 39 | BRSK1 | 1.09882642 |
| 40 | TRPM7 | 1.04641382 |
| 41 | LYN | 1.04510542 |
| 42 | CSF1R | 1.04508468 |
| 43 | MST4 | 1.04474372 |
| 44 | WNK1 | 1.03447528 |
| 45 | GRK7 | 0.87104362 |
| 46 | NME1 | 0.85343984 |
| 47 | IRAK4 | 0.78554150 |
| 48 | PIM1 | 0.75390435 |
| 49 | CHUK | 0.75070574 |
| 50 | ACVR1B | 0.74531992 |
| 51 | MAP3K11 | 0.69910093 |
| 52 | RPS6KA5 | 0.66446692 |
| 53 | HCK | 0.65631915 |
| 54 | DAPK2 | 0.65570466 |
| 55 | JAK1 | 0.64140453 |
| 56 | BLK | 0.60674389 |
| 57 | CSNK1G3 | 0.59837230 |
| 58 | TGFBR2 | 0.55828311 |
| 59 | MUSK | 0.54753034 |
| 60 | INSRR | 0.54499727 |
| 61 | STK38L | 0.53011771 |
| 62 | MAP3K12 | 0.52323758 |
| 63 | CSNK1G2 | 0.51062620 |
| 64 | TNK2 | 0.50824454 |
| 65 | STK10 | 0.50441921 |
| 66 | NUAK1 | 0.49708366 |
| 67 | ADRBK1 | 0.48880779 |
| 68 | MAPK7 | 0.47901207 |
| 69 | MYLK | 0.46265718 |
| 70 | GRK5 | 0.45640484 |
| 71 | DAPK1 | 0.45293154 |
| 72 | * IGF1R | 0.45208437 |
| 73 | CSNK1A1L | 0.44167210 |
| 74 | PHKG1 | 0.43750080 |
| 75 | PHKG2 | 0.43750080 |
| 76 | MAPKAPK2 | 0.41077753 |
| 77 | TESK1 | 0.40998056 |
| 78 | BMPR2 | 0.39052115 |
| 79 | TYK2 | 0.39038810 |
| 80 | PRKAA2 | 0.37912589 |
| 81 | CSNK1G1 | 0.37448935 |
| 82 | EPHA2 | 0.35679380 |
| 83 | PTK2B | 0.35371880 |
| 84 | OBSCN | 0.34922009 |
| 85 | MAP3K1 | 0.34418955 |
| 86 | ABL1 | 0.34122081 |
| 87 | FRK | 0.33832429 |
| 88 | JAK2 | 0.32875185 |
| 89 | MATK | 0.32115628 |
| 90 | RPS6KA1 | 0.32040190 |
| 91 | RPS6KA4 | 0.31143950 |
| 92 | INSR | 0.30848247 |
| 93 | PIK3CG | 0.30617967 |
| 94 | FYN | 0.30569590 |
| 95 | MAPK3 | 0.28918960 |
| 96 | CDC42BPA | 0.28804308 |
| 97 | ABL2 | 0.28445985 |
| 98 | PKN1 | 0.26201889 |
| 99 | PRKCA | 0.25559851 |
| 100 | PIK3CA | 0.25534959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.08958693 |
| 2 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 3.73347552 |
| 3 | * Allograft rejection_Homo sapiens_hsa05330 | 3.70247885 |
| 4 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.61744139 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.05358730 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.82568982 |
| 7 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.81009692 |
| 8 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.80560443 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64073381 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.50461907 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.37739810 |
| 12 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17825282 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13924522 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12083019 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04456170 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.01968715 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.94894903 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.91746218 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.83225743 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74068123 |
| 21 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.71390803 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58915398 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57293939 |
| 24 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.56739740 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40462917 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.39391568 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34488349 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30191936 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29826135 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26454509 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.25585034 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18539095 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13590411 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.10597828 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 0.96899976 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95403156 |
| 37 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.94656697 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94251716 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89757069 |
| 40 | Ribosome_Homo sapiens_hsa03010 | 0.89100791 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88673638 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85729356 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85457469 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82532264 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.81545295 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81293977 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.81115766 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77425110 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75498323 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.73859116 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73554490 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72574006 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71119234 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70954626 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 0.68168449 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.67029958 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66172574 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.65592841 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63107481 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62533499 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61448308 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.59930779 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59877744 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.58889682 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56933707 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56110328 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55662859 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55533907 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54669951 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52720703 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52148300 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51155263 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47203384 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.46910172 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46216905 |
| 76 | * Phagosome_Homo sapiens_hsa04145 | 0.46160632 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44131823 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42472490 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41387433 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40789777 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38200808 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37681518 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37404600 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36713129 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.36680118 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35276914 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34466984 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32738777 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32303109 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28695746 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.27355060 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26052491 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.24904328 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24764288 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24128101 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23086747 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21827612 |
| 98 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.21430227 |
| 99 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17363130 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.16795823 |

